Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2795-2800

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hashimoto, M.
Right arrow Articles by Ouchi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hashimoto, M.
Right arrow Articles by Ouchi, Y.
Related Collections
Right arrow Doppler ultrasound, Transcranial Doppler etc.
Right arrow Pathology of Stroke
Right arrow Endothelium/vascular type/nitric oxide
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2795.)
© 1999 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Correlation Between Flow-Mediated Vasodilatation of the Brachial Artery and Intima-Media Thickness in the Carotid Artery in Men

Masayoshi Hashimoto; Masato Eto; Masahiro Akishita; Koichi Kozaki; Junya Ako; Katsuya Iijima; Seungbum Kim; Kenji Toba; Masao Yoshizumi; Yasuyoshi Ouchi

From the Department of Geriatric Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

Correspondence to Yasuyoshi Ouchi, MD, PhD, Department of Geriatric Medicine, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail youchi-tky{at}umin.u-tokyo.ac.jp


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract—Endothelial dysfunction has been reported to be the initial step in atherosclerosis. A noninvasive technique that uses ultrasound to measure the intima-media thickness of the carotid artery has been applied to evaluate localized atherosclerosis. This study was undertaken to elucidate whether endothelial dysfunction in the brachial artery is related to the intima-media thickness of the carotid artery. Thirty-four men with atherosclerosis (mean±SE age 61±2 years) and 33 age-matched men without clinical atherosclerosis were examined. The intima-media thickness and plaque formation of the common carotid artery were assessed by B-mode ultrasonography. We also noninvasively measured brachial artery diameter by the same ultrasound machine when the subjects were at rest, during reactive hyperemia, which causes endothelium-dependent vasodilatation, and after sublingual administration of nitroglycerin, which causes endothelium-independent vasodilatation. The atherosclerosis group had a significantly greater intima-media thickness of the common carotid artery than did the control group (1.02±0.04 versus 0.91±0.03 mm, P<0.05). The flow-mediated diameter (FMD) increase (percent FMD={Delta}D/Dx100) in the atherosclerosis group was significantly smaller than that in the control group (2.8±0.4% versus 5.1±0.6%, P<0.01). A significant negative correlation between the intima-media thickness of the carotid artery and percent FMD was found in all of the subjects. On multiple regression analysis, percent FMD showed a significant negative correlation with the intima-media thickness of the common carotid artery. These findings support the concept that endothelial dysfunction is significantly related to atherogenesis.


Key Words: vasodilatation • endothelium • carotid artery • atherosclerosis


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Evidence has accumulated that impairment of vascular endothelial function is the initial step in the development of atherosclerosis.1 One important finding is the impaired release of endothelium-dependent relaxing factor, which is now thought to be NO or its related substances, from endothelial cells.1 Flow-mediated dilatation (FMD) induced by reactive hyperemia has been known to be endothelium dependent,2 and this phenomenon can be detected during reactive hyperemia by high-resolution ultrasound in superficial arteries.3 4 Several coronary risk factors such as hypercholesterolemia,5 smoking,6 and hyperhomocysteinemia4 have been reported to be significantly related to decreased FMD. However, no study has been reported to demonstrate an association between increased intima-media thickness (IMT) of the carotid artery and decreased FMD.

A noninvasive technique that uses B-mode ultrasonography can visualize and assess the lumen and vessel wall of the carotid artery. We analyzed IMT of the right common carotid artery by using this method.7 IMT thickening consists of both an intimal atherosclerotic process and medial hypertrophy. Because IMT is increased in subjects with familial hypercholesterolemia8 and shows a progressive reduction with cholesterol-lowering treatment,9 10 IMT seems to be significantly related to the early phase of atherosclerosis.

This study was undertaken to elucidate whether impaired endothelial function in the brachial artery is related to IMT thickening in the common carotid artery. Because of the significant correlation between IMT and coronary or cerebrovascular disease,11 12 13 14 15 16 we examined the clinical significance of increased IMT in relation to impaired endothelial function in the study subjects.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Subjects
Thirty-four men with atherosclerosis aged 61.1±2.0 years (mean±SE) and 33 age-matched men without clinical atherosclerosis (controls) were enrolled in this study. These subjects were recruited from outpatient clinics, inpatient wards, and community volunteers. A history and physical examination were obtained, and laboratory tests were performed in all subjects to exclude diseases other than hypertension, hyperlipidemia, and diabetes mellitus. Exclusion criteria for this study included clinical manifestations of cerebrovascular disease, venous thromboembolism, or liver disorders and a personal history of cancer(s). The inclusion criteria for the atherosclerosis group were as follows: (1) coronary artery disease, confirmed by coronary arteriography and/or a documented history of myocardial infarction within 5 years; (2) a clinical diagnosis of arteriosclerosis obliterans. All subjects were interviewed about their drinking and smoking habits. Each subject gave written, informed consent before enrollment in this study, after receiving a thorough explanation of the study design and protocol. This study was in agreement with the guidelines approved by the ethics committee at our institution.

Study Design
Each subject made 1 visit to the University of Tokyo Hospital. Blood sampling was performed in the morning of the examination, after a 14-hour overnight fast, to measure the serum lipid profile and other biochemical parameters. Serum total cholesterol and triglyceride concentrations were measured enzymatically, and the serum HDL cholesterol concentration was measured by the heparin–Ca2+Ni2+ precipitation method.17 Plasma glucose concentration was assayed by the glucose oxidase method, and the hemoglobin A1c level was measured by high-performance liquid chromatography.

Measurement of IMT of the Carotid Artery
Ultrasound measurements of IMT of the common carotid artery were performed by an examiner who was unaware of the subjects’ clinical backgrounds. IMT of the carotid artery was measured from high-resolution, 2-dimensional ultrasound images obtained by an SSA-270A ultrasound machine (Toshiba) with a 7.5-MHz linear-array transducer.

The subject reclined on the examination table for 15 minutes before the initial carotid ultrasound scanning. IMT measurement of the carotid artery was performed according to the method of Salonen and Salonen as described previously18 19 20 in a quiet, temperature-controlled (22°C to 24°C) room. This measurement was applied to the far wall of the right carotid artery. While subjects were in the supine position, a linear-array ultrasound probe (7.5 MHz), which was part of the same ultrasound machine, was applied longitudinally to the surface of the skin on the right side of the neck. Longitudinal scanning was performed from the common carotid artery to the bifurcation of the common carotid artery. Scanning was performed in the optimal position. Blood pressure was monitored in the left arm every 2 minutes during the study by an automated blood pressure recorder. An ECG monitor integrated with the ultrasound machine was also applied. The ultrasound images were recorded on S-VHS videotape with an SLV-RS7 videocassette recorder (Sony). After the bifurcation of the common carotid artery was confirmed, IMT was measured from the B-mode screen with electronic calipers to within 10 mm proximal to the bifurcation. Four points were measured in 1 scan, which was synchronized with the R-wave peaks on the ECG to avoid possible errors resulting from variable arterial compliance. Two scans were made for each study subject. The mean IMT was calculated from 8 points. The variability of the ultrasound measurements of IMT was studied by performing 5 measurements over 1 month in 12 volunteers. The coefficient of variation for measurement of IMT was 4.20±0.67%.

Measurement of Flow-Mediated and Nitroglycerin-Induced Dilatation of the Brachial Artery
After the carotid ultrasound scanning, flow-mediated dilatation (FMD) and nitroglycerin (NTG)-induced dilatation of the brachial artery were measured by the examiner who performed the carotid ultrasound study. Studies of FMD and NTG-induced dilatation were performed according to the method described previously.3 4 21 The examinations were conducted by the same examiner throughout the study. The diameter of the artery was measured from high-resolution, 2-dimensional ultrasound images obtained by an ultrasound machine with a 7.5-MHz linear-array transducer. Machine operating parameters were kept constant during each study.

The right brachial artery was scanned over a longitudinal section 3 to 5 cm above the right elbow. Depth and gain settings were optimized to identify the lumen-to-vessel wall interface. Automated blood pressure recording in the left arm was continued every 2 minutes during the study. An ECG monitor integrated with the ultrasound machine was also applied. When an adequate image was obtained, the surface of the skin was marked, and the arm was kept in the same position throughout the study. A pneumatic tourniquet placed around the forearm distal to the target artery was inflated to a pressure of 250 mm Hg, and inflation was held for 5 minutes. Increased flow was then induced by sudden cuff deflation. A second scan was performed continuously for 60 seconds before and for 120 seconds after cuff deflation. Then, 15 minutes later, another resting scan was recorded to confirm vessel recovery. Sublingual NTG spray (300 µg, Myocol spray, Toa Eiyo Co) was then administered, and 3 to 5 minutes later the last scan was performed.

The ultrasound images were recorded on S-VHS videotape with an SLV-RS7 videocassette recorder (Sony). The diameter of the brachial artery was measured from the anterior to the posterior interface between the media and adventitia ("m line") at a fixed distance.20 The mean diameter was calculated from 4 cardiac cycles synchronized with the R-wave peaks on the ECG. All measurements were made at end diastole to avoid possible errors resulting from variable arterial compliance.22 Maximal vasodilatation was observed 45 to 60 seconds after cuff release.3 21 The diameter change caused by FMD was expressed as the percent change relative to that at the initial resting scan (percent FMD). The diameter change caused by NTG was expressed in the same way, as the percent change relative to that at the recovery scan (percent NTG-induced dilatation). The pulse-wave velocity profile of blood flow was simultaneously recorded. Mean flow velocity was calculated by measuring the area under this velocity profile curve. Blood flow (in milliliters per minute) was then calculated by multiplying the cross-sectional area of the brachial artery, which was based on the diameter and the mean flow velocity. Changes in diameter of 0.1 to 0.2 mm can be detected accurately with this method.4 8 18 The coefficient of variation for measurements of percent FMD was 5.84±0.25% and that for percent NTG-induced dilatation was 3.97±0.24%, as we reported before.21

Statistical Analysis
All data in the text, tables, and figures are expressed as mean±SEM. Differences between the 2 groups were analyzed by Student’s unpaired t test. Simple correlation of percent FMD with IMT and of percent NTG-induced dilatation with IMT was determined. Standardized regression coefficients from multiple regression analysis of IMT in relation to various factors were analyzed. A value of P<0.05 was considered statistically significant.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Clinical Characteristics
Thirty of the 34 subjects with atherosclerosis regularly took NTG products for clinical reasons. On the other hand, 1 of the 33 subjects without clinical atherosclerosis had been prescribed an NTG product by his family doctor for chest discomfort. The clinical and metabolic characteristics of the 34 men with atherosclerosis and of the 33 men without clinical atherosclerosis (controls) are presented in Table 1Down. Age, body mass index, and mean blood pressure of the men with atherosclerosis were not statistically different from those of the men without clinical atherosclerosis. Serum total cholesterol, HDL cholesterol, triglyceride, fasting plasma glucose, and hemoglobin A1c levels were similar between the 2 groups. The percent prevalences of hypertension, hyperlipidemia, diabetes mellitus, and current smoking are presented in Table 1Down, and these were not statistically different between the 2 groups.


View this table:
[in this window]
[in a new window]
 
Table 1. Clinical and Metabolic Characteristics of the Study Subjects

Two men without clinical atherosclerosis and 6 men with atherosclerosis were taking 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Six men without clinical atherosclerosis and 18 men with atherosclerosis were taking calcium channel antagonists (P<0.01). Five men without clinical atherosclerosis and 8 men with atherosclerosis were taking angiotensin-converting enzyme inhibitors. Three men without clinical atherosclerosis and 2 men with atherosclerosis were taking ß-blockers. Two men without clinical atherosclerosis and 1 man with atherosclerosis were taking diuretics.

Measurement of IMT of the Common Carotid Artery
We made observations of the right carotid artery only. All of the study subjects were relatively young, and no obvious carotid plaques were observed in this study group. As shown in Figure 1Down, IMT of the common carotid artery of the subjects with atherosclerosis was significantly greater than that of subjects without clinical atherosclerosis (1.02±0.04 versus 0.91±0.03 mm, P<0.05). Among the subjects without clinical atherosclerosis, IMT was not significantly different between nonsmokers and smokers (0.88±0.04 versus 0.96±0.04 mm). Among the subjects with clinical atherosclerosis, IMT was not significantly different between nonsmokers and smokers either (0.98±0.05 versus 1.06±0.05 mm). When we measured the intraobserver error for mean IMT, it was 0.043±0.03 mm (coefficient of variation 4.2%).



View larger version (36K):
[in this window]
[in a new window]
 
Figure 1. IMT in subjects with and without clinical atherosclerosis. *Significant difference between the groups indicated at P<0.05.

FMD and NTG-Induced Dilatation of the Brachial Artery
All subjects tolerated the study well. There were no significant differences in the brachial artery diameter at rest (5.05±0.09 mm in the subjects without atherosclerosis versus 5.27±0.10 mm in the subjects with atherosclerosis) and the magnitude of reactive hyperemia produced by cuff inflation and release in the 2 groups (data not shown). As shown in Figure 2Down, the percent FMD in the subjects with atherosclerosis was significantly smaller than that of subjects without clinical atherosclerosis (2.78±0.43% versus 5.10±0.59%, P<0.01). Among the subjects without clinical atherosclerosis, percent FMD was not significantly different between nonsmokers and smokers (5.62±0.69% versus 4.39±1.02%). Among the subjects with clinical atherosclerosis, the percent FMD in smokers was lower than that in nonsmokers (1.99±0.50% versus 3.79±0.68%, P<0.05). The percent NTG-induced dilatation in the subjects with atherosclerosis was also significantly smaller than that of subjects without clinical atherosclerosis (7.83±0.68% versus 12.28±0.83% P<0.01). Among the subjects without clinical atherosclerosis, the percent NTG-induced dilatation was not significantly different between nonsmokers and smokers (11.91±1.00% versus 12.78±1.43%). Among the subjects with clinical atherosclerosis, the percent NTG-induced dilatation was not significantly different between nonsmokers and smokers (8.58±1.04% versus 7.24±0.91%). The percent FMD was significantly related to the percent NTG-induced dilatation by simple regression analysis in the subjects without atherosclerosis, in the subjects with atherosclerosis, and in all subjects combined (r=-0.56, P=0.0004; r=-0.77, P<0.0001; and r=-0.71, P<0.0001, respectively).



View larger version (19K):
[in this window]
[in a new window]
 
Figure 2. Percent FMD and percent NTG-induced dilatation in subjects with and without clinical atherosclerosis. Percent increases in vessel diameter of the right brachial artery induced by FMD and by NTG were measured by ultrasound technique as described in Methods. Data are expressed as mean±SEM. **Significant difference between the groups indicated at P<0.01.

IMT of the Common Carotid Artery and Percent FMD of the Brachial Artery
To investigate the relationship between IMT and percent FMD, the following analysis was performed in the 67 subjects. As shown in Figure 3Down, IMT was inversely related to percent FMD by simple regression analysis (r=-0.36, P<0.01). When the subjects with atherosclerosis were excluded, IMT was still inversely related to percent FMD (r=-0.38, P<0.05). Multiple regression analysis was performed to investigate whether percent FMD was an independent variable related to IMT. Table 2Down shows standardized regression coefficients of IMT in relation to age, body mass index, mean blood pressure, percent FMD, serum total cholesterol, serum HDL cholesterol, serum triglyceride, fasting plasma glucose, and plasma hemoglobin A1c levels. This analysis showed that IMT was inversely related to percent FMD only (P<0.05).



View larger version (25K):
[in this window]
[in a new window]
 
Figure 3. Simple correlation of IMT with percent FMD and percent NTG in men with atherosclerosis, in men without atherosclerosis, and in both groups combined.


View this table:
[in this window]
[in a new window]
 
Table 2. Standardized Regression Coefficients From Multiple Linear Regression Analysis of IMT in Relation to Independent Variables in 67 Subjects

IMT of the Common Carotid Artery and Percent NTG-Induced Dilatation of the Brachial Artery
IMT was also inversely related to percent NTG-induced dilatation by simple regression analysis in the 67 subjects (r=-0.31, P<0.05). However, when the subjects were divided into 2 groups (ie, those with and without atherosclerosis) as shown in Figure 3Up, IMT was not inversely related to percent NTG-induced dilatation in either group. On multiple regression analysis, IMT was not significantly related to age, body mass index, mean blood pressure, percent NTG-induced dilatation, serum total cholesterol, serum HDL cholesterol, serum triglyceride, fasting plasma glucose, and plasma hemoglobin A1c levels.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
IMT of the common carotid artery as measured by B-mode ultrasonography is thought to be an initial pathological change secondary to the atherosclerotic process. IMT of the common carotid artery has been used as a noninvasive end point in epidemiological studies and clinical trials to assess the progression and regression of atherosclerosis in the body.12 Carotid arterial IMT, expressed as a single measurement or a rate of change, is used as a surrogate end point for atherosclerosis of the coronary arteries.12 13 14 15 16 On the other hand, FMD in the brachial artery has recently been used to detect endothelial function and is widely accepted as a noninvasive technique.3 There have been few reports, however, demonstrating the relationship between FMD in the brachial artery and coronary artery endothelial function.23 Furthermore, the relationship between FMD in the brachial artery and the progression of coronary artery disease and/or its related events has not been demonstrated. Therefore, before FMD in the brachial artery becomes a useful surrogate for assessing the predisposition to atherosclerosis in patients, the relationship between IMT of the common carotid artery and FMD in the brachial artery will need to be determined.24

This study showed that IMT of the common carotid artery of subjects with atherosclerosis was significantly greater than that in subjects without clinical atherosclerosis. At the same time, endothelium-dependent vasodilatation in subjects with atherosclerosis was significantly smaller than that in subjects without clinical atherosclerosis. Endothelium-independent vasodilatation induced by NTG in subjects with atherosclerosis was also significantly smaller than that in subjects without clinical atherosclerosis. Atherosclerotic vessels, which are characterized by smooth muscle proliferation, may have an impaired smooth muscle response to NO, which is produced either by the endothelium or by sublingual nitrate administration. Furthermore, almost 90% of the subjects with atherosclerosis in this study had been prescribed nitrates. Regular use of nitrates may itself induce an impaired smooth muscle response to NO, manifested as "tolerance." However, percent FMD was also significantly related to percent NTG-induced dilatation by simple regression analysis in the subjects without atherosclerosis. This suggests that early in the process of atherosclerosis, arterial wall changes are not only present as impaired endothelial function but also as functional changes in smooth muscle cell responses to endothelium-derived and/or exogenous nitro compounds. The mechanism underlying this remains unclear. It is possible that microscopic arterial structural changes may exist before the development of macroscopic anatomic changes.25 26

IMT was inversely related to percent FMD and percent NTG-induced dilatation by simple regression analysis for all subjects. When the subjects with atherosclerosis were excluded, IMT was inversely related to percent FMD only. Among the subjects with atherosclerosis, IMT was not related to either percent FMD or percent NTG-induced dilatation. This finding suggests that before the development of macroscopic anatomic atherosclerosis, IMT is well correlated with endothelial dysfunction. Multiple regression analysis also confirmed that percent FMD was an independent variable related to IMT. Furthermore, several subjects with atherosclerosis had a relatively thin IMT and a decreased percent FMD. This result may suggest that some subjects have impaired endothelial function before developing an early stage of atherosclerosis that can be measured as IMT. Therefore, it is important to know not only IMT but also endothelial function. We are not completely sure at this point that endothelial dysfunction precedes development of the early stages of atherosclerosis.

Active and passive smoking has been reported to be significantly involved in endothelial function6 27 and the progression of IMT.28 29 Smoking may have influenced the results of percent FMD and IMT in this study also. Actually, among the subjects with clinical atherosclerosis, even though IMT was not different with respect to smoking status, the percent FMD in smokers was lower than that of nonsmokers (1.99±0.50% versus 3.79±0.68%, P<0.05). However, the number of current smokers in both groups was not statistically different, and thus, it is likely that smoking habit did not influence our conclusions.

IMT of the common carotid artery can be reduced by cholesterol-lowering treatment.10 30 31 32 Pravastatin treatment in hyperlipidemic patients has resulted in a statistically significant reduction in IMT progression in the common carotid artery, and pravastatin treatment has also been associated with a reduction in fatal and nonfatal coronary events.32 The degree of carotid artery atherosclerosis as measured by B-mode ultrasound has been shown to be strongly and independently correlated with the presence of coronary atherosclerotic disease.11 25 Increased IMT of the common carotid artery has been shown to be an indicator of generalized atherosclerosis and to be associated with future cerebrovascular and cardiovascular events.12 13 14 15 16 These reports support the hypothesis that carotid arteriosclerosis may reflect generalized atherosclerosis.

Increased IMT of the common carotid artery and impaired FMD in the brachial artery are thought to be the initial steps in atherosclerosis, and they may even be reversible. Identifying patients without overt atherosclerosis but who have cardiovascular risk factor(s) is of clinical importance. Further studies are needed to evaluate the healthy population with or without risk factor(s).

In conclusion, the present study demonstrated a significant relationship between carotid artery IMT and endothelium-dependent vasodilatation in the brachial artery. These findings support the idea that endothelial dysfunction is significantly related to atherogenesis.


*    Acknowledgments
 
This study was supported by a grant-in-aid (No. 11470157 to Y.O.) for Scientific Research from the Ministry of Education, Science and Culture of Japan. We thank all of the volunteers who participated in the present study. We also thank Dr Kazuhide Yamaoki and Masae Watanabe for their cooperation in this study.

Received December 15, 1998; accepted April 13, 1999.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801–809.[Medline] [Order article via Infotrieve]

2. Nabel EG, Selwyn AP, Ganz P. Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol. 1990;16:349–356.[Abstract]

3. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111–1115.[Medline] [Order article via Infotrieve]

4. Sorensen KE, Celermajer DS, Georgakopoulos D, Hatcher G, Betteridge DJ, Deanfield JE. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. J Clin Invest. 1994;93:50–55.

5. Celermajer DS, Sorensen K, Ryalls M, Robinson J, Thomas O, Leonard JV, Deanfield JE. Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol. 1993;22:854–858.[Abstract]

6. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 1993;88:2149–2155.[Abstract/Free Full Text]

7. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399–1406.[Abstract/Free Full Text]

8. Wendelhag I, Wiklund O, Wikstrand J. Arterial wall thickness in familial hypercholesterolemia: ultrasound measurement of intima-media thickness in the common carotid artery. Arterioscler Thromb. 1992;12:70–77.[Abstract/Free Full Text]

9. Clarkson TB, Adams MR, Kaplan JR, Shively CA, Koritnik DR. From menarche to menopause: coronary artery atherosclerosis and protection in cynomolgus monkeys. Am J Obstet Gynecol. 1989;160:1280–1285.[Medline] [Order article via Infotrieve]

10. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu C, Liu C, Alaupovic P, Kwong FH, Azen SP. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med. 1996;124:548–556.[Abstract/Free Full Text]

11. Wofford JL, Kahl FR, Howard GR, McKinney WM, Toole JF, Crouse JD. Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arterioscler Thromb. 1991;11:1786–1794.[Abstract/Free Full Text]

12. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991;11:1245–1249.[Abstract/Free Full Text]

13. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997;96:1432–1437.[Abstract/Free Full Text]

14. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993. Am J Epidemiol. 1997;146:483–494.[Abstract/Free Full Text]

15. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, Azen SP. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med. 1998;128:262–269.[Abstract/Free Full Text]

16. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999;340:14–22.[Abstract/Free Full Text]

17. Noma A, Okabe H, Netsu NK, Ueno Y, Shinohara H. Improved method for simultaneous determination of cholesterol in high- and low-density lipoproteins. Clin Chem. 1979;25:1480–1481.[Abstract/Free Full Text]

18. Salonen R, Salonen JT. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med. 1991;229:225–231.[Medline] [Order article via Infotrieve]

19. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation. 1993;87(suppl II):II-56–II-65.

20. Wendelhag I, Gustavsson T, Suurkula M, Berglund G, Wikstrand J. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol. 1991;11:565–577.[Medline] [Order article via Infotrieve]

21. Hashimoto M, Akishita M, Eto M, Ishikawa M, Kozaki K, Toba K, Sagara Y, Taketani Y, Orimo H, Ouchi Y. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation. 1995;92:3431–3435.[Abstract/Free Full Text]

22. Reneman RS, van Merode T, Hick P, Muytjens AM, Hoeks AP. Age-related changes in carotid artery wall properties in men. Ultrasound Med Biol. 1986;12:465–471.[Medline] [Order article via Infotrieve]

23. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995;26:1235–1241.[Abstract]

24. Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med. 1996;125:605–613.[Abstract/Free Full Text]

25. Sorensen KE, Kristensen IB, Celermajer DS. Atherosclerosis in the human brachial artery. J Am Coll Cardiol. 1997;29:318–322.[Abstract]

26. Dakak N, Husain S, Mulcahy D, Andrews NP, Panza JA, Waclawiw M, Schenke W, Quyyumi AA. Contribution of nitric oxide to reactive hyperemia: impact of endothelial dysfunction. Hypertension. 1998;32:9–15.[Abstract/Free Full Text]

27. Celermajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, Deanfield JE. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med. 1996;334:150–154.[Abstract/Free Full Text]

28. Diez RA, Nieto FJ, Comstock GW, Howard G, Szklo M. The relationship of active and passive smoking to carotid atherosclerosis 12–14 years later. Prev Med. 1995;24:48–55.[Medline] [Order article via Infotrieve]

29. Howard G, Wagenknecht LE, Burke GL, Diez RA, Evans GW, McGovern P, Nieto FJ, Tell GS. Cigarette smoking and progression of atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. JAMA. 1998;279:119–124.[Abstract/Free Full Text]

30. Blankenhorn DH, Selzer RH, Crawford DW, Barth JD, Liu CR, Liu CH, Mack WJ, Alaupovic P. Beneficial effects of colestipol-niacin therapy on the common carotid artery: two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation. 1993;88:20–28.[Abstract/Free Full Text]

31. Furberg CD, Adams HJ, Applegate WB, Byington RP, Espeland MA, Hartwell T, Hunninghake DB, Lefkowitz DS, Probstfield J, Riley WA, et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events: Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation.. 1994;90:1679–1687.[Abstract/Free Full Text]

32. Crouse JR, Byington RP, Bond MG, Espeland MA, Craven TE, Sprinkle JW, McGovern ME, Furberg CD. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II) [published erratum appears in Am J Cardiol. 199515;75:862.] Am J Cardiol. 1995;75:455–459.[Medline] [Order article via Infotrieve]




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
F. Bilora, M. T. Sartori, E. Zanon, E. Campagnolo, M. Arzenton, and A. Rossato
Flow-Mediated Arterial Dilation in Primary Antiphospholipid Syndrome
Angiology, February 1, 2009; 60(1): 104 - 107.
[Abstract] [PDF]


Home page
HypertensionHome page
S. Ashfaq, J. L. Abramson, D. P. Jones, S. D. Rhodes, W. S. Weintraub, W. C. Hooper, V. Vaccarino, R. W. Alexander, D. G. Harrison, and A. A. Quyyumi
Endothelial Function and Aminothiol Biomarkers of Oxidative Stress in Healthy Adults
Hypertension, July 1, 2008; 52(1): 80 - 85.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
H. Komai, Y. Higami, H. Tanaka, K. Honda, M. Juri, and Y. Okamura
Impaired Flow-Mediated Endothelium-Dependent and Endothelium-Independent Vasodilation of the Brachial Artery in Patients With Atherosclerotic Peripheral Vascular Disease
Angiology, March 1, 2008; 59(1): 52 - 56.
[Abstract] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
F. Bilora, E. Zanon, A. Casonato, A. Bertomoro, F. Petrobelli, M. Cavraro, E. Campagnolo, and A. Girolami
Type IIB von Willebrand Disease: Role of Qualitative Defects in Atherosclerosis and Endothelial Dysfunction
Clinical and Applied Thrombosis/Hemostasis, October 1, 2007; 13(4): 384 - 390.
[Abstract] [PDF]


Home page
Eur Heart JHome page
K. K. Naka, A. C. Tweddel, S. N. Doshi, J. Goodfellow, and A. H. Henderson
Flow-mediated changes in pulse wave velocity: a new clinical measure of endothelial function
Eur. Heart J., February 1, 2006; 27(3): 302 - 309.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. T. Yan, T. J. Anderson, F. Charbonneau, L. Title, S. Verma, E. Lonn, and on behalf of the FATE Investigators
Relationship Between Carotid Artery Intima-Media Thickness and Brachial Artery Flow-Mediated Dilation in Middle-Aged Healthy Men
J. Am. Coll. Cardiol., June 21, 2005; 45(12): 1980 - 1986.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. L. Moens, I. Goovaerts, M. J. Claeys, and C. J. Vrints
Flow-Mediated Vasodilation: A Diagnostic Instrument, or an Experimental Tool?
Chest, June 1, 2005; 127(6): 2254 - 2263.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. L. Bots, J. Westerink, T. J. Rabelink, and E. J.P. de Koning
Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response
Eur. Heart J., February 2, 2005; 26(4): 363 - 368.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. Nagaoka, Y. Ishii, T. Takeuchi, A. Takahashi, E. Sato, and A. Yoshida
Relationship between the Parameters of Retinal Circulation Measured by Laser Doppler Velocimetry and a Marker of Early Systemic Atherosclerosis
Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 720 - 725.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Juonala, J. S.A. Viikari, T. Laitinen, J. Marniemi, H. Helenius, T. Ronnemaa, and O. T. Raitakari
Interrelations Between Brachial Endothelial Function and Carotid Intima-Media Thickness in Young Adults: The Cardiovascular Risk in Young Finns Study
Circulation, November 2, 2004; 110(18): 2918 - 2923.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. L. Lazar
Role of statin therapy in the coronary bypass patient
Ann. Thorac. Surg., August 1, 2004; 78(2): 730 - 740.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. H. Slyper
What Vascular Ultrasound Testing Has Revealed about Pediatric Atherogenesis, and a Potential Clinical Role for Ultrasound in Pediatric Risk Assessment
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3089 - 3095.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Y. Chan, G. B. J. Mancini, L. Kuramoto, M. Schulzer, J. Frohlich, and A. Ignaszewski
The prognostic importance of endothelial dysfunction and carotid atheromaburden in patients with coronary artery disease
J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1037 - 1043.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Frick, S. P. Schwarzacher, H. F. Alber, A. Rinner, H. Ulmer, O. Pachinger, and F. Weidinger
Morphologic rather than functional or mechanical sonographic parameters of the brachial artery are related to angiographically evident coronary atherosclerosis
J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1825 - 1830.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Hashimoto, H. Akita, T. Hayashi, T. Tsunekawa, H. Kano, D. Sumi, H. Matsui-Hirai, N. K. Thakur, A. Iguchi, and K. Egashira
Cerivastatin, a Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor, Improves Endothelial Function in Elderly Diabetic Patients Within 3 Days Response
Circulation, January 29, 2002; 105 (4): e30 - e31.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Imamura, S. Biro, T. Kihara, S. Yoshifuku, K. Takasaki, Y. Otsuji, S. Minagoe, Y. Toyama, and C. Tei
Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors
J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1083 - 1088.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
J. Spacil, R. Ceska, and T. Haas
Flow-Dependent Vasomotor Dysfunction of the Popliteal Artery Related to Common Carotid Artery Intima-Media Thickness
Angiology, October 1, 2001; 52(10): 689 - 695.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
P. Lundman, M. J. Eriksson, M. Stuhlinger, J. P. Cooke, A. Hamsten, and P. Tornvall
Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine
J. Am. Coll. Cardiol., July 1, 2001; 38(1): 111 - 116.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Kubis, A. Checoury, A. Tedgui, and B. I. Levy
Adaptive common carotid arteries remodeling after unilateral internal carotid artery occlusion in adult patients
Cardiovasc Res, June 1, 2001; 50(3): 597 - 602.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. Kraiczi, K. Caidahl, A. Samuelsson, Y. Peker, and J. Hedner
Impairment of Vascular Endothelial Function and Left Ventricular Filling : Association With the Severity of Apnea-Induced Hypoxemia During Sleep
Chest, April 1, 2001; 119(4): 1085 - 1091.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hashimoto, M.
Right arrow Articles by Ouchi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hashimoto, M.
Right arrow Articles by Ouchi, Y.
Related Collections
Right arrow Doppler ultrasound, Transcranial Doppler etc.
Right arrow Pathology of Stroke
Right arrow Endothelium/vascular type/nitric oxide